United States · FDA National Drug Code directory
CNJ-016
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60492-0173_ad4abcf6-88ca-41ff-a0f0-75692c8d517c
- Product NDC
- 60492-0173
- Form
- INJECTION
- Composition / generic term
- Vaccinia Immune Globulin Intravenous (Human)
- Labeler
- Emergent BioSolutions Canada Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20050502
- Source listing expiry
- 20271231
Source-listed ingredients
- HUMAN VACCINIA VIRUS IMMUNE GLOBULIN — 1 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 VIAL, SINGLE-USE in 1 CARTON (60492-0173-2) / 12 mL in 1 VIAL, SINGLE-USE (60492-0173-1) · 60492-0173-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →